# British Business Bank ‘throws kitchen sink’ at life sciences to address dearth of UK investment

- URL: https://talkfuse.com/story/british-business-bank-throws-kitchen-sink-at-life-sciences-to-address-dearth-of-uk-investment/
- Published: 2026-11-18T00:01:00+00:00
- Updated: 2026-11-18T00:21:49+00:00
- Original publisher: City AM (publisher lean: Right)
- Original article: https://www.cityam.com/british-business-bank-throws-kitchen-sink-at-life-sciences-to-address-dearth-of-uk-investment/
- Topics: Business, UK, World

## Key points

- The bank’s life sciences backing has reached £1.1bn.
- Pension investment in private markets has largely gone to property.
- The bank is also courting European funds to back UK firms.

## Summary

The British Business Bank has increased its backing for UK life sciences to £1.1bn, aiming to help domestic companies grow and attract more pension-fund investment. Its chief investment officer says financing the sector requires a broad effort, as specialist firms need larger pools of capital to scale in Britain.

The backing includes £832m across 20 life sciences funds and £302m for domestic scale-ups, including £25m for Alchemab Therapeutics and £15m for T-Therapeutics. Pension funds signed up to the Mansion House Accord have pledged to put 5% of assets into private markets by 2030, but 70% of £11.1bn committed so far has gone to property and only £500m to private equity. The bank has also committed €58m to a European fund, while sector leaders point to overseas acquisitions and limited research facilities as challenges for UK growth.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
